Who makes human single chain IL-12 mRNA-single dose?

human single chain IL-12 mRNA-single dose is developed by Cancer Institute and Hospital, Chinese Academy of Medical Sciences.

What development phase is human single chain IL-12 mRNA-single dose in?

human single chain IL-12 mRNA-single dose is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Phase 1 active Biologic Quality 0/100

Generic name	human single chain IL-12 mRNA-single dose
Sponsor	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Modality	Biologic
Phase	Phase 1

No approved indications tracked.

No common side effects on file.

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results